Improving cancer treatment for children with HIV in Sub-Saharan Africa
Establishing a Platform for Clinical Improvement for Children with HIV-Associated Malignancies in Sub-Saharan Africa
This study is working to improve cancer treatment for kids under 12 with HIV in Sub-Saharan Africa, aiming to help them live healthier lives by using better care and support from local doctors.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10895426 on NIH RePORTER |
What this research studies
This research aims to enhance the treatment outcomes for children under 12 years old who are diagnosed with HIV-associated cancers in Sub-Saharan Africa. It addresses the alarming survival rates, which are below 20%, by establishing a collaborative clinical trial network focused on pediatric HIV/AIDS and related malignancies. The project will implement standardized treatment protocols across multiple sites to improve access to care and outcomes for these vulnerable patients. By leveraging partnerships with local healthcare providers, the initiative seeks to integrate antiretroviral therapy with cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years who are diagnosed with HIV and associated cancers in Sub-Saharan Africa.
Not a fit: Patients who are not diagnosed with HIV or do not have HIV-associated malignancies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve survival rates and quality of life for children suffering from HIV-associated malignancies.
How similar studies have performed: Previous research has shown that collaborative treatment approaches can improve outcomes for pediatric cancer patients, suggesting a promising potential for this initiative.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Allen, Carl E — Baylor College of Medicine
- Study coordinator: Allen, Carl E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.